Form 4: David Mott, Ardelyx Director, Acquires 213,300 Shares of Common Stock
SEC Form 4 Filing
Director David Mott purchased 213,300 shares of Ardelyx, Inc. common stock at an average price of $4.6722 on December 19, 2024.
Summary
- On December 19, 2024, David Mott, a director of Ardelyx, Inc., acquired 213,300 shares of common stock.
- The purchase was made at a weighted average price of $4.6722 per share, with individual trades ranging from $4.55 to $4.75.
- Following the transaction, Mott directly owns 1,638,765 shares of Ardelyx common stock.
- Mott also holds 87,566 shares for the benefit of entities associated with New Enterprise Associates but disclaims beneficial ownership except for his pecuniary interest.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's overall health.
Positives
- A director's purchase of a significant number of shares can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC when a company insider, such as a director, buys or sells shares of their company's stock. It provides transparency to the market regarding insider transactions.
Stakeholder Impact
- Shareholders may view the director's purchase as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 12/19/2024 | Date of transaction: David Mott purchased 213,300 shares of Ardelyx common stock. |
| 12/23/2024 | Date of report: Form 4 filing date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.